182 related articles for article (PubMed ID: 22747465)
21. Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia.
Ladroue C; Hoogewijs D; Gad S; Carcenac R; Storti F; Barrois M; Gimenez-Roqueplo AP; Leporrier M; Casadevall N; Hermine O; Kiladjian JJ; Baruchel A; Fakhoury F; Bressac-de Paillerets B; Feunteun J; Mazure N; Pouysségur J; Wenger RH; Richard S; Gardie B
Haematologica; 2012 Jan; 97(1):9-14. PubMed ID: 21933857
[TBL] [Abstract][Full Text] [Related]
22. The novel prolyl hydroxylase-2 inhibitor caffeic acid upregulates hypoxia inducible factor and protects against hypoxia.
Guo Z; Yang Y; Li L; Zhao Q; Li Y; Liu Z; Hao L; Guo B; Diao A
Eur J Pharmacol; 2022 Nov; 934():175307. PubMed ID: 36191632
[TBL] [Abstract][Full Text] [Related]
23. Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1).
Chowdhury R; Flashman E; Mecinović J; Kramer HB; Kessler BM; Frapart YM; Boucher JL; Clifton IJ; McDonough MA; Schofield CJ
J Mol Biol; 2011 Jul; 410(2):268-79. PubMed ID: 21601578
[TBL] [Abstract][Full Text] [Related]
24. Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2.
Figg WD; Fiorini G; Chowdhury R; Nakashima Y; Tumber A; McDonough MA; Schofield CJ
Proteins; 2023 Nov; 91(11):1510-1524. PubMed ID: 37449559
[TBL] [Abstract][Full Text] [Related]
25. Spectroscopic studies of the mononuclear non-heme Fe(II) enzyme FIH: second-sphere contributions to reactivity.
Light KM; Hangasky JA; Knapp MJ; Solomon EI
J Am Chem Soc; 2013 Jul; 135(26):9665-74. PubMed ID: 23742069
[TBL] [Abstract][Full Text] [Related]
26. Significance of prolyl hydroxylase 2 in the interference of aryl hydrocarbon receptor and hypoxia-inducible factor-1 alpha signaling.
Seifert A; Katschinski DM; Tonack S; Fischer B; Navarrete Santos A
Chem Res Toxicol; 2008 Feb; 21(2):341-8. PubMed ID: 18072750
[TBL] [Abstract][Full Text] [Related]
27. The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability.
Barth S; Nesper J; Hasgall PA; Wirthner R; Nytko KJ; Edlich F; Katschinski DM; Stiehl DP; Wenger RH; Camenisch G
Mol Cell Biol; 2007 May; 27(10):3758-68. PubMed ID: 17353276
[TBL] [Abstract][Full Text] [Related]
28. Prolyl hydroxylase domain 2 protein suppresses hypoxia-induced endothelial cell proliferation.
Takeda K; Fong GH
Hypertension; 2007 Jan; 49(1):178-84. PubMed ID: 17101841
[TBL] [Abstract][Full Text] [Related]
29. Expression of the cellular oxygen sensor PHD2 (EGLN-1) predicts radiation sensitivity in squamous cell cancer of the head and neck.
Luukkaa M; Jokilehto T; Kronqvist P; Vahlberg T; Grénman R; Jaakkola P; Minn H
Int J Radiat Biol; 2009; 85(10):900-8. PubMed ID: 19639506
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of a prolyl hydroxylase domain (PHD) by substrate analog peptides.
Kwon HS; Choi YK; Kim JW; Park YK; Yang EG; Ahn DR
Bioorg Med Chem Lett; 2011 Jul; 21(14):4325-8. PubMed ID: 21665470
[TBL] [Abstract][Full Text] [Related]
31. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
[TBL] [Abstract][Full Text] [Related]
32. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
33. Src activates HIF-1α not through direct phosphorylation of HIF-1α specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase/Rac pathway.
Lee HY; Lee T; Lee N; Yang EG; Lee C; Lee J; Moon EY; Ha J; Park H
Carcinogenesis; 2011 May; 32(5):703-12. PubMed ID: 21335603
[TBL] [Abstract][Full Text] [Related]
34. Increased Turnover at Limiting O2 Concentrations by the Thr(387) → Ala Variant of HIF-Prolyl Hydroxylase PHD2.
Pektas S; Taabazuing CY; Knapp MJ
Biochemistry; 2015 May; 54(18):2851-7. PubMed ID: 25857330
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
Hewitson KS; Schofield CJ; Ratcliffe PJ
Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
[TBL] [Abstract][Full Text] [Related]
36. The regulation, localization, and functions of oxygen-sensing prolyl hydroxylase PHD3.
Jaakkola PM; Rantanen K
Biol Chem; 2013 Apr; 394(4):449-57. PubMed ID: 23380539
[TBL] [Abstract][Full Text] [Related]
37. Prolyl hydroxylase domain protein 2 (PHD2) mediates oxygen-induced retinopathy in neonatal mice.
Duan LJ; Takeda K; Fong GH
Am J Pathol; 2011 Apr; 178(4):1881-90. PubMed ID: 21435465
[TBL] [Abstract][Full Text] [Related]
38. Tetrahydropyridin-4-ylpicolinoylglycines as novel and orally active prolyl hydroxylase 2 (PHD2) inhibitors for the treatment of renal anemia.
Su K; Li Z; Zhang L; Fang S; Mao M; Sun Z; Zhang X
Eur J Med Chem; 2022 Aug; 238():114479. PubMed ID: 35675755
[TBL] [Abstract][Full Text] [Related]
39. A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo.
Minamishima YA; Moslehi J; Padera RF; Bronson RT; Liao R; Kaelin WG
Mol Cell Biol; 2009 Nov; 29(21):5729-41. PubMed ID: 19720742
[TBL] [Abstract][Full Text] [Related]
40. The oxygen sensor prolyl hydroxylase domain 2 regulates the in vivo suppressive capacity of regulatory T cells.
Ajouaou Y; Azouz A; Taquin A; Denanglaire S; Hussein H; Krayem M; Andris F; Moser M; Goriely S; Leo O
Elife; 2022 Feb; 11():. PubMed ID: 35192456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
